Nalaganje...

Plasma cytokine and angiogenic factors associated with prognosis and therapeutic response to sunitinib vs everolimus in advanced non-clear cell renal cell carcinoma

No biomarkers are available to predict relative clinical benefit from targeted therapies in patients with non-clear cell renal cell carcinoma (nccRCC). To identify candidate predictive markers, we investigated a set of cytokines and angiogenic factors (CAFs) in previously untreated patients with ncc...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Msaouel, Pavlos, Zurita, Amado J., Huang, Shixia, Jonasch, Eric, Tannir, Nizar M.
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5522056/
https://ncbi.nlm.nih.gov/pubmed/28178674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15011
Oznake: Označite
Brez oznak, prvi označite!